AMPK: An Ambiguous Position for Atrial Fibrillation
AMPK: An Ambiguous Position for Atrial Fibrillation
复制标题
AMPK:心房颤动的模糊定位
DOI:
10.1016/j.tem.2018.02.009
复制
发表时间:
2018-06
期刊:
影响因子:
--
通讯作者:
Qiming Liu
中科院分区:
文献类型:
--
作者:
Jiayi Li;Fan Bai;Biao Li;Qiming Liu
We have read with great interest the review of Day and colleagues entitled ‘AMPK as a Therapeutic Target for Treating Metabolic Diseases’[1]. In their review, they demonstrate that AMP-activated protein kinase (AMPK) activity promotes an anti-inflammatory phenotype, protects against obesity-induced insulin resistance, prevents liver lipid accumulation, and maintains mitochondrial function in various cell types such as hepatocytes, macrophages, and adipocytes. This information will certainly be useful in guiding the development of AMPK-targeted therapeutics to treat chronic metabolic diseases. As was noted above, AMPK appears to possess a positive intrinsic characteristic. Current accumulating research has also provided evidence that AMPK might have a potential role in cardiac electrophysiology and arrhythmia [2]. In addition, AMPK can cause lipid accumulation, reduce glucose uptake, and increase glycogen synthesis, and these promote the imbalance of energy supply contrary to expectations. Furthermore, AMPK activation appears to mediate the metabolic change in irregularly paced myocytes, as experiments conducted in the presence of Compound c, a cell-permeable ATP-competitive AMPK inhibitor, result in [47_TD $ DIFF] upregulation of FAT-CD36 and GLUT-4, and this metabolic remodeling may contribute in part to the pathology of atrial fibrillation (AF)[3].
登录
查看更多内容
影响因子:
2.7
作者:
C. Conti
通讯作者:
C. Conti
影响因子:
9.5
作者:
Lenski, Matthias;Schleider, Gregor;Laufs, Ulrich
通讯作者:
Laufs, Ulrich
影响因子:
24
作者:
Harada, Masahide;Tadevosyan, Artavazd;Nattel, Stanley
通讯作者:
Nattel, Stanley
影响因子:
20.1
作者:
Zaha VG;Young LH
通讯作者:
Young LH
影响因子:
8.4
作者:
Harada, Masahide;Nattel, Sarah Naomi;Nattel, Stanley
通讯作者:
Nattel, Stanley